2.3.2. Thromboembolism

Direct Oral Anticoagulants (DOACs) are recommended as first line treatment over Vitamin K
antagonists (warfarin) for treatment in newly initiated patients with non-valvular atrial fibrillation
(NVAF) as per NICE NG196

For NICE NG 196 and Kent & Medway Position Statement Click here

2.3.2.1 Antiplatelet drugs
2.3.2.2 Factor Xa inhibitors
2.3.2.3 Reversal Agents
2.3.2.4 Heparins
2.3.2.5 Thrombin Inhibitors
2.3.2.6 Vitamin K antagonists
2.3.2.7 Tissue Plasminogen Activators

First Line Choice
On Formulary
Specialist Initiation Only

Hospital Only
KMPT Initiation Only